Clinical Trials Directory

Trials / Completed

CompletedNCT05730660

Quercetin Phytosome® Chronic Fatigue Symptoms

Effectiveness of a 3-months Dietary Supplementation Based on Quercetin Phytosome®) for the Treatment of Chronic Fatigue Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Azienda di Servizi alla Persona di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether a 3-month period of quercetin supplementation (500 mg of Quercetin Phytosome®) is useful in the treatment of chronic fatigue, as assessed by the Fatigue Impact Scale (FIS-40). Secondary end points are sleep assessment through Pittsburgh Sleep Quality Index (PSQI) and muscle performance assessment through the Short Physical Performance Battery (SPPB) and body composition assessment using DXA.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTQuercetin group2 capsules a day of Quercetin Fitosoma® of 250 mg each
DIETARY_SUPPLEMENTPlacebo group2 tablets per day, white film-coated having the same appearance as Quercetin Fitosoma ® tablets.

Timeline

Start date
2022-09-01
Primary completion
2022-12-31
Completion
2023-01-31
First posted
2023-02-16
Last updated
2024-08-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05730660. Inclusion in this directory is not an endorsement.